Adjuvant management of locally advanced oral squamous cell carcinoma – real-world challenges and opportunities

a.sfakia shared this article with you from Inoreader Adjuvant management of locally advanced oral squamous cell carcinoma – real-world challenges and opportunities Via Oral and Maxillofacial Surgery Patients with locally advanced oral squamous cell cancer (LAOSCC) are treated with adjuvant radiotherapy (RT) or chemoradiotherapy (CRT) following surgical ablation. This depends on the pathological risk factors and aims to reduce the risk of local recurrence and improve survival. Delivery of these aggressive treatments is, however, challenging particularly following major surgery. To inform the adaptations necessary to deliver gold-standard therapy, we aimed to describe real-world delivery of multimodality treatment in LAOSCC, in a UK population with high levels of disease incidence and low socioeconomic status. View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.